Finance

Lists
011040:KOSDAQ
Kyung Dong Pharmaceutical Co Ltd
₩4,960.00
+0.30%
(+15.00) 1D
Jul 23, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 011040...
Open
₩4,945
High
₩4,965
Low
₩4,915
Mkt. cap
152.61B
Avg. vol.
29.90K
Volume
11.03K
Dividend
6.05%
Quarterly dividend
₩75
Ex-dividend date
Dec 29, 2025
P/E ratio
11.70
52-wk high
₩6,890
52-wk low
₩4,700
EPS
₩424
Shares outstanding
30.77M
No. of employees
350
Open
₩4,945
High
₩4,965
Low
₩4,915
Mkt. cap
152.61B
Avg. vol.
29.90K
Volume
11.03K
Dividend
6.05%
Quarterly dividend
₩75
Ex-dividend date
Dec 29, 2025
P/E ratio
11.70
52-wk high
₩6,890
52-wk low
₩4,700
EPS
₩424
Shares outstanding
30.77M
No. of employees
350
News stories
From sources across the web
About Kyung Dong Pharmaceutical Co Ltd
CEORyu Deok-Hee
Employees350
Founded1975
Headquarters-
SectorPharmaceutical industry
Websitekdpharma.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
49.42B
48.88B
52.16B
47.81B
Cost of goods sold
20.60B
19.32B
21.72B
18.17B
Cost of revenue
20.60B
19.32B
21.72B
18.17B
Research and development expenses
2.62B
1.03B
2.48B
2.27B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.27B
25.04B
24.95B
24.33B
Operating expense
28.33B
26.47B
27.88B
27.23B
Total operating expenses
48.94B
45.79B
49.59B
45.40B
Operating income
478.36M
3.09B
2.57B
2.41B
Other non operating income
-354.10M
-9.54M
-275.41M
-525.57M
EBT including unusual items
-995.01M
5.06B
3.38B
5.79B
EBT excluding unusual items
-58.93M
3.17B
2.55B
3.66B
Income tax expense
-571.59M
651.02M
545.55M
1.07B
Effective tax rate
57.45%
12.86%
16.12%
18.43%
Other operating expenses
158.37M
102.45M
125.84M
292.56M
Net income
-416.22M
4.42B
2.89B
4.74B
Net profit margin
-0.84%
9.04%
5.53%
9.92%
Earnings per share
-
-
-
-
Interest and investment income
456.81M
545.11M
569.79M
1.20B
Interest expense
-494.26M
-454.94M
-411.90M
-430.01M
Net interest expenses
-37.45M
90.17M
157.89M
766.63M
Depreciation and amortization charges
214.33M
211.15M
233.68M
226.64M
EBITDA
1.36B
4.03B
3.56B
3.43B
Gain or loss from assets sale
1.12M
-1.35B
-926.68M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer